AXA (CS) PT Set at €23.50 by Citigroup

AXA (EPA:CS) has been given a €23.50 ($27.33) price objective by analysts at Citigroup in a report issued on Thursday. The firm currently has a “neutral” rating on the stock. Citigroup’s target price would indicate a potential upside of 3.07% from the stock’s current price.

CS has been the topic of several other research reports. UBS Group set a €21.50 ($25.00) price target on AXA and gave the company a “neutral” rating in a report on Monday, August 20th. Societe Generale set a €30.00 ($34.88) price target on AXA and gave the company a “buy” rating in a report on Friday, August 3rd. BNP Paribas set a €26.00 ($30.23) price target on AXA and gave the company a “buy” rating in a report on Tuesday, September 11th. Deutsche Bank set a €27.00 ($31.40) price target on AXA and gave the company a “buy” rating in a report on Monday, September 3rd. Finally, Goldman Sachs Group set a €27.00 ($31.40) price target on AXA and gave the company a “buy” rating in a report on Tuesday, August 28th. Three investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. AXA currently has a consensus rating of “Buy” and a consensus target price of €26.89 ($31.26).

EPA:CS traded up €0.23 ($0.27) during midday trading on Thursday, hitting €22.80 ($26.51). 14,250,000 shares of the stock were exchanged, compared to its average volume of 9,520,000. AXA has a one year low of €22.13 ($25.73) and a one year high of €27.69 ($32.20).

AXA Company Profile

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates through six segments: France, Europe, Asia, the United States, International, and Transversal and Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

Read More: Why do companies issue stock splits?

Analyst Recommendations for AXA (EPA:CS)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply